Luxonus
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
N/A | JPY50.0m | Series A | |
JPY600m | Series A | ||
JPY430m | Series B | ||
N/A | JPY100m | Late VC | |
N/A | Late VC | ||
Total Funding | €8.3m |
Recent News about Luxonus
EditLuxonus Inc. is a pioneering company in the medical imaging sector, specializing in the development and commercialization of photoacoustic imaging devices. These devices provide a novel method for visualizing tiny blood vessels in 3D, offering significant advancements over traditional imaging techniques. Luxonus serves healthcare providers, research institutions, and medical device manufacturers, primarily operating in the global medical imaging market. The company employs a business model centered on the sale and licensing of its proprietary imaging technology, generating revenue through direct sales, partnerships, and ongoing service agreements. By leveraging cutting-edge technology, Luxonus aims to enhance diagnostic accuracy and improve patient outcomes.
Keywords: photoacoustic imaging, medical imaging, 3D visualization, blood vessels, healthcare, diagnostics, proprietary technology, commercialization, global market, patient outcomes.